Mylan finalizes settlement with the U.S. Justice Department, resolving claims it overcharged the government for its EpiPen. CBC | Health News
Tag: Mylan
Mylan shareholders hate how much money board of directors makes
Enlarge / Heather Bresch, CEO of Mylan NV, refers to a chart while speaking during a House Oversight and Government Reform Committee hearing in Washington, DC on Wednesday, Sept. 21, 2016. (credit: Getty | Bloomberg) A whopping 83 percent of Mylan shareholders voted down the company’s astronomical executive compensation packages. But a majority of shareholders still […]
Shareholders fail to oust Mylan board, but down-voted massive salaries
Enlarge / Robert J. Coury of Mylan (L) and Mylan CEO Heather Bresch will remain on the board. (credit: Getty | Gilbert Carrasquillo) Mylan shareholders today did not unseat the drug maker’s board of directors, despite calls for an ouster over the EpiPen pricing scandals and remarkably large executive salaries. In a vote during an […]
Mylan shareholders revolt, say directors’ greed has gone too far
Enlarge / Heather Bresch, chief executive officer of Mylan NV, is questioned by lawmakers over why the company raised the price of the life-saving injection to $ 600 for a two-pack from $ 57 a shot. (credit: Getty | Andrew Harrer/Bloomberg ) A group of disgruntled Mylan investors launched a campaign late Tuesday to block […]
FDA lashes out at Mylan for dismal quality control at HIV drug facility
Enlarge / Heather Bresch, chief executive officer of drugmaker Mylan Inc. (credit: Getty | Bloomberg) Mylan—the pharmaceutical company infamous for raising the price of EpiPens—is in hot water with the Food and Drug Administration. This time, the dust-up is related to the quality control practices at one of the company’s drug facilities making antiretroviral therapies […]
EpiPen maker Mylan faces proposed class action lawsuit in U.S.
Pharmaceutical firm Mylan NV has been hit with a new proposed class action lawsuit in the U.S. over the price of its EpiPen allergy treatment, which shot up to more than $ 600 US for a two-pack of the device from less than $ 100 in 2007. CBC | Health News